Adjuvant endocrine therapy is one of the most effective tools in breast cancer treatment — and one of the hardest for patients to stay on. Dr. Corinne Menn, menopause specialist and breast cancer survivor, gives clinicians an evidence-based framework for managing side effects and supporting long-term adherence.

BRCA carriers face unique and often misunderstood risks when it comes to menopausal hormone therapy — and blanket avoidance can cause real harm. Dr. Joanne Kotsopoulos presents the current evidence on MHT safety in BRCA1 and BRCA2 carriers and provides clinicians with a practical framework for individualized decision-making.

A menopause-specialist review of testosterone therapy in breast cancer survivors, with practical guidance for individualized risk assessment and symptom management.

A one-day, in-person CME covering menopause management, MHT prescribing, GLP-1 therapies, cardiometabolic risk, and breast cancer screening — led by nationally recognized women's health faculty. 7 AMA PRA Category 1 Credits™. June 19, 2026, Cincinnati, OH.

A clinical review of hormonal and non-hormonal approaches to managing treatment-induced menopause in gynecologic oncology, with practical guidance for survivorship care.

Ekta Kapoor delivers a focused clinical review of estetrol (E4) for oncomenopause clinicians — covering mechanism of action, current evidence, and the emerging case for its use in menopause management in cancer survivors.

An evidence-based overview of cardio-oncology, focusing on cardiovascular risk, treatment-related cardiotoxicity, and long-term heart health in cancer survivors.

Adult survivors of childhood cancer represent a growing and clinically complex population — one that women's health and oncomenopause providers are increasingly likely to encounter and often feel underprepared to serve. Drs. Eary and Erickson, whose careers are built around bridging the gap between oncology and survivorship primary care, deliver a practical, evidence-informed session on what clinicians need to know when these patients walk through their door.

An evidence-based review of menopause management strategies for gynecologic cancer survivors, with practical guidance for individualized, survivorship-centered care.

Dr. Milana Dolezal delivers a rigorous evidence review of non-hormonal menopause management options for breast cancer survivors — cutting through the noise to examine what the data actually supports for pharmacologic and non-pharmacologic interventions in this population.